Join OBR for free to stay up-to-date with all OBR initiatives: events, consulting opportunities, partner initiatives, biotech opportunities, and more. You need to be a registered member in order to be able to sign up to our events.

The Commercial Potential of Big Data in Biotech

Event Registration

Please enter a few personal details to register for this event.
  • Please enter your name as it will appear on your name tag.

  • $0.00

Few pairs of words have become more hyped recently than “Big Data”. This couplet has become a much-lauded, but often poorly-understood, term in the tech and business worlds. Reams of consumer data are being used for “smart” advertising. However, the transformational power of Big Data in the life science and healthcare industries is only beginning to be tapped.

Mountains of medically-relevant data are being amassed from disparate sources such as microarrays, next-generation sequencing, wearable sensors, and electronic medical records. This data deluge is driven by the increasing throughput of these technologies and the ability to store the data, combined with decreasing associated costs. For example, the Human Genome Project took 10 years and $3 billion to appreciate 20,000 genes and 3 billion bases. Today, the goal of $1000 per genome in a single day may only be months away – a precipitous decline in time and cost outpacing Moore’s law.

With falling costs for greater technological capabilities, the potential of Big Data to improve health care in a commercially-viable way is approaching an inflection point. In Southern California, companies and hospitals have been taking notice- the UC Irvine health system recently implemented a large-scale data infrastructure project, and LA-based NantHealth unveiled a supercomputer network capable of quickly analysing a tumor genome and comparing it with data from thousands of cancer patients to allow personalized treatment.

As Thomas Jackiewicz, CEO of USC’s Keck Medical Center, said: “We have to become experts at managing data.” However, managing the data is only part of the equation- asking the right questions of the data is also essential. In this spirit, here we will ask:

–          What is (and can) being done with all of this data?

–          What questions are being asked, and what can we ask?

–          How do we take mountains of this data and translate it into clinically relevant outcomes?

–          Where are the largest commercial life science opportunities in Big Data over the next 5 years?

–          How are companies in the LA area merging Big Data and healthcare to generate value for themselves and for consumers?


big data event flyer LA

Parking information:

Street parking
on E. California Blvd and Wilson Ave

Campus parking lot (Free after 5pm)
Structure #3 (California parking structure) about 50 meters south past the Cahill center and tennis court
Visitor permit may be purchased at the following rates.

  • 1 hour permit: $2
  • 2 hour permit: $3
  • 3 hour permit: $4




Speakers at this event

charles boicey picture

Charles Boicey - Informatics Solutions Architect, UCI Medical Center

Speaker bio
david kale

David Kale - Data Researcher, USC & Former Lead Data Scientist, CHLA

Speaker bio
Andy lee

Dr. Andy Lee - Director of the Diabetes and Metabolic Clinic, LAC & USC Medical Center

Speaker bio
Los Angeles Chapter Event

When & Where

  • Cahill Center for Astronomy and Astrophysics at Caltech
  • 1216 East California Boulevard, California Institute of Technology, Pasadena, CA 91107, USA
  • Thursday, 10th October 2013 @ 5:00pm

Event attendees

    This event currently has 137 attendees, including:

  • A Christian J Riley, Cedars Sinai Medical Center
  • Ada Leung
  • Akshat Khanna, Graduate Student, University of Southern California
  • Alex Zelhofer
  • Allan Wong, Caltech
  • Amarpreet Bains, USC
  • Andres Collazo, California Institute of Technology
  • Andrew Carl Dagis, City of Hope
  • Anita Ramanathan, University of Southern California
  • Annabel Beichman, UCLA
  • Anuja Raut, USC School of Pharmacy
  • April Yang, Keck Graduate Institute
  • Ariel YC Chen, Caltech
  • Armand Ryden, VA
  • Axel Muller, Caltech
  • Beisi Xu, City of Hope
  • Bruce Lathrop, Law Office of Bruce D. Lathrop
  • charles beichman, Caltech
  • Chas Syndergaard, KGI
  • chelsea robertson, UCLA
  • Cole Schaffer, Keck Graduate Institute
  • Colt Egelston, City of Hope
  • Daniel Perez, Oxford
  • Darren Kessner, UCLA
  • Darryl Nousome
  • David W. Chung, Keck Graduate Institute of Applied Life Sciences
  • Elizabeth Jane McIlvaine, University of Southern California, Keck School of Medicine
  • Emily HM Wong, USC
  • Eric Hsu, KGI
  • Eter Rodríguez, Keck Graduate Institute
  • Fabien AGENES, Embassy of France in the US
  • Frances Katherine Pillsbury, Keck Graduate Institute
  • Frank Fletcher, OnSiteLegal
  • Garnet Kim, Keck Graduate Institute of Applied Life Sciences
  • Genhua Jin, USC
  • Gerrit Brand, BionCR Development
  • Gregory Solis, The Scripps Research Institute
  • Gully APC Burns, USC / ISI
  • Haiqing Li, City of Hope
  • Haodong Chen, UCLA
  • Hemanth Ramaprakash, University of Southern California, Marshall School of Business
  • Henry Poon, HBCI
  • Ian Phillips, Keck Graduate Institute
  • Jaebum (Albert) Chung, Caltech
  • James Hemp, CCalifornia Institute of Technology
  • Jane Sur, Keck Graduate Institute of Applied Life Sciences
  • Janet Chung, City of Hope
  • Jason Eng, USC Marshall
  • Jason Wang, Sino-American Biomedical and Pharmaceutical Professional Association (SABPA)
  • Jesus Cuaron, Keck Graduate Institute
  • Jiehua Zhou, Beckman research institute of City of hope
  • Joel Greggain, Keck Graduate Institute
  • Joseph (Joe) Jackiewicz, USC Marshall School of Business
  • Juan Du, City of Hope
  • Katherine Yang
  • Kato Shum, City of Hope
  • Kevin Dawson
  • Kosalai Kaliappan, Keck Graduate Institute
  • Krissia Manansala, Keck Graduate Institute
  • Lakshmi Dharmarajan, Keck Graduate Institute
  • LIJUN HE, usc
  • Lingwen Gan, California Institute of Technology
  • Lisa Dahm, UC Irvine
  • Marc Jung, City Of Hope
  • Maria Filippou, Keck Graduate Institute
  • Mark Brown, Claremont BioSolutions
  • Martha Pastuszka, University of Southern California
  • Mary Donhoffner, University of Southern California
  • Maya Otto-Duessel, City of Hope
  • Michael Weist, City of Hope
  • Mohan Sundaram Rathinasamy
  • Monika Polewski, City of Hope, OBR
  • Nan Wang, USC
  • Nan Wu, UC Irvine
  • Nikhil J Joshi, CalTech
  • Nikhilesh Sanyal, Keck Gradute Institute
  • Nimish Gopal, KGI Student
  • Ning Huang, University of Southern California
  • Oscar J Edwards, AgriCept Inc_CSIC
  • Pamela Bonar, Keck Graduate Institute
  • Paul Schuber, Keck Graduate Institute
  • Peter P. Lee, MD, City of Hope Cancer Center
  • PP Vaidyanathan, Caltech
  • Prasanna Adhikari
  • Prashant Doma
  • Purnima Singh, City of Hope
  • Qiuyu Guo, USC
  • Quoclinh Nguyen, Cedars Sinai
  • Quoclinh Nguyen, Cedars Sinai Medical Center
  • Ramesh Gajraj
  • Rania Nasis, Society of Physician Entrepreneurs
  • Rohan Mondkar, Keck Graduate Institute of Applied Life Sciences
  • Sagar Damle, Caltech
  • Sailesh Gopalakrishna-Pillai, CITY OF HOPE
  • Sascha Hasan, Sanguine Biosciences
  • Sean Caenepeel, Amgen
  • Sergey Nechaev, City of Hope
  • Shabnam Hakimi
  • Siarhei Manakou, Caltech
  • Simone Chen, Growthink
  • Suketu Patel, University of Oxford
  • Susan Graham
  • Thomas Luu, Keck Graduate Institute
  • Tommy R. Sun-Wing Tong, City of Hope
  • veran dong
  • Victoria Wu, City of Hope
  • vijay chickarmane, caltech
  • Vivian Y. Chang, UCLA
  • Vlad Grishkevich, Caltech
  • Wan-Qing Yu, USC
  • Wanwan Yang, Caltech
  • William Van Noll, USC Marshall
  • Wuchen Zhao
  • Yair Crane, ECS Data Security
  • Yate-Ching Yuan, Beckman Research Institute, City of Hope Medical Center
  • Ye Zhou, City of Hope
  • Zach Shao
  • Zlatka Stojanova, USC

Contribute to the OBR community - subscribe today for free


Copyright © 2015 Oxbridge Roundtable Ltd - All Rights Reserved